Men with aggressive prostate cancer who were being treated with a groundbreaking drug have been told the therapy is no longer available at public hospitals. Lutetium PSMA was being compounded locally, but after a pharmaceutical giant took legal action, public hospitals say they can't offer the treatment anymore.
